Cizzle Net Income Applicable To Common Shares from 2010 to 2024

CIZ Stock   1.80  0.05  2.70%   
Cizzle Biotechnology's Net Loss is decreasing over the years with slightly volatile fluctuation. Net Loss is expected to dwindle to about -861.8 K. Net Loss is the net income that remains after preferred dividends have been deducted, available to common shareholders. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
-820.8 K
Current Value
-861.8 K
Quarterly Volatility
973.3 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cizzle Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cizzle Biotechnology's main balance sheet or income statement drivers, such as Depreciation And Amortization of 927, Interest Expense of 7.5 M or Total Revenue of 0.0, as well as many indicators such as . Cizzle financial statements analysis is a perfect complement when working with Cizzle Biotechnology Valuation or Volatility modules.
  
This module can also supplement various Cizzle Biotechnology Technical models . Check out the analysis of Cizzle Biotechnology Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Cizzle Stock

Cizzle Biotechnology financial ratios help investors to determine whether Cizzle Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cizzle with respect to the benefits of owning Cizzle Biotechnology security.